Theragran-M
This article was originally published in The Tan Sheet
Executive Summary
Walgreens has acquired the rights from Bristol-Myers Squibb to act as exclusive distributor of Theragran-M Advanced formula multivitamins, the company announces Sept. 19. "Over the last 50 years, Theragran multivitamins have earned significant customer trust and loyalty worldwide," Walgreens category manager Robert Bobber said. "The brand's strong heritage and reputation for promoting proper nutrition make it an excellent fit for Walgreens." Theragran-M will retain its original packaging, with the addition of "exclusively distributed by Walgreens" added to the label, according to a company spokesperson. The brand, which BMS retired in 2005, will be available in Walgreens in October...
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.